latest news releases from the newsroom
LGL Group, Inc.
The LGL Group, Inc. Reports Results for 2007
ORLANDO, Fla., May 13, 2008 (PRIME NEWSWIRE) -- The LGL Group, Inc. (AMEX:LGL) (the "Company"), today announced results for the year ended December 31, 2007. Total revenues for the year ended December 31, 2007 were $39,536,000, a decrease of 4.8% from the year ended December 31, 2006. Loss from continuing operations for the year ended December 31, 2007 was $555,000 compared to income from continuing operations of $2,946,000. Included in the 2007 loss from continuing operations was an impairment loss on Lynch Systems' assets of $905,000. There was a net loss of $2,554,000, or ($1.18) per share, in 2007 compared with a restated net income of $956,000, or $0.44 per share, in 2006.
FortuNet Announces Earnings Call for the Quarter Ended March 31, 2008
LAS VEGAS, May 13, 2008 (PRIME NEWSWIRE) -- FortuNet, Inc. (the "Company") (Nasdaq:FNET) today filed with the Securities and Exchange Commission its quarterly report on Form 10-Q for the quarter ended March 31, 2008 and announced that it will conduct a conference call to discuss these results on May 15, 2008 at 1:00 P.M., Pacific Standard Time. To participate in the conference call, please dial 1-866-296-6505 and enter the authorization number 5437787.
Apria Healthcare Group Inc.
Apria Healthcare Announces Agreement With Smith & Nephew, Inc. to Provide Negative Pressure Wound Therapy Services and Products
LAKE FOREST, Calif., May 13, 2008 (PRIME NEWSWIRE) -- Apria Healthcare Group Inc. (NYSE:AHG) announced that it has signed a preferred provider agreement with Smith & Nephew (LSE:SN) (NYSE:SNN) to provide Negative Pressure Wound Therapy (NPWT) services and products to the United States homecare market. The preferred provider agreement covers the rental of Smith & Nephew's EZCARE(tm) and V1STA(tm) product systems and sale of associated disposables for the treatment of complex wounds.
Gencor Industries, Inc.
Gencor's Perspective On Trading May 13, 2008
ORLANDO, Fla., May 13, 2008 (PRIME NEWSWIRE) -- In view of the accelerated trading of the Company's stock, and for the benefit of those who persist on remaining uninformed in spite of all of Gencors (Nasdaq:GENC) SEC filings, 10-K's, 8-K's, Proxy Statements, Annual Reports and Press Releases, the following statements were made by E.J. Elliott, CEO of Gencor:
MediciNova to Present At the Rodman and Renshaw 5th Annual Global Healthcare Conference
SAN DIEGO, May 13, 2008 (PRIME NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Hercules Market of the Osaka Securities Exchange (Code Number:4875), today announced that Shintaro Asako, Chief Financial Officer of MediciNova, will present a company overview at the Rodman and Renshaw 5th Annual Global Healthcare Conference on Monday, May 19, 2008 at 8:40 a.m. local time (2:40 a.m. Eastern time). The conference is being held at the Le Meridien Beach Plaza Hotel in Monaco, Monte Carlo.